The following is a summary of “Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review,” published in the March 2025 issue of Advances in Rheumatology by Carvalho & Skare. Rituximab (RTX) and intravenous immunoglobulin (IVIg) are established treatments for autoimmune diseases. Their combined use is rare and understudied. Researchers conducted a retrospective study […]
The post Evaluating Rituximab and Intravenous Immunoglobulin in Autoimmune Treatment first appeared on Physician’s Weekly.
